Free Trial

Arogo Capital Acquisition (AOGO) Competitors

Arogo Capital Acquisition logo
$11.21 +0.01 (+0.09%)
(As of 12/20/2024 12:40 PM ET)

AOGO vs. CDLX, CMCM, CCRD, CSPI, MAPS, EGAN, SKIL, SSTI, AILE, and ISSC

Should you be buying Arogo Capital Acquisition stock or one of its competitors? The main competitors of Arogo Capital Acquisition include Cardlytics (CDLX), Cheetah Mobile (CMCM), CoreCard (CCRD), CSP (CSPI), WM Technology (MAPS), eGain (EGAN), Skillsoft (SKIL), SoundThinking (SSTI), iLearningEngines (AILE), and Innovative Solutions and Support (ISSC). These companies are all part of the "computer software" industry.

Arogo Capital Acquisition vs.

Cardlytics (NASDAQ:CDLX) and Arogo Capital Acquisition (NASDAQ:AOGO) are both small-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, risk, dividends, earnings, profitability, valuation, media sentiment, institutional ownership and analyst recommendations.

Arogo Capital Acquisition has lower revenue, but higher earnings than Cardlytics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardlytics$293.47M0.64-$134.70M-$6.11-0.61
Arogo Capital AcquisitionN/AN/AN/AN/AN/A

68.1% of Cardlytics shares are owned by institutional investors. Comparatively, 41.6% of Arogo Capital Acquisition shares are owned by institutional investors. 4.4% of Cardlytics shares are owned by insiders. Comparatively, 2.4% of Arogo Capital Acquisition shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Cardlytics had 1 more articles in the media than Arogo Capital Acquisition. MarketBeat recorded 1 mentions for Cardlytics and 0 mentions for Arogo Capital Acquisition. Cardlytics' average media sentiment score of 0.50 beat Arogo Capital Acquisition's score of 0.00 indicating that Cardlytics is being referred to more favorably in the media.

Company Overall Sentiment
Cardlytics Positive
Arogo Capital Acquisition Neutral

Cardlytics received 225 more outperform votes than Arogo Capital Acquisition when rated by MarketBeat users.

CompanyUnderperformOutperform
CardlyticsOutperform Votes
225
57.40%
Underperform Votes
167
42.60%
Arogo Capital AcquisitionN/AN/A

Cardlytics presently has a consensus price target of $6.92, indicating a potential upside of 86.43%. Given Cardlytics' stronger consensus rating and higher probable upside, analysts clearly believe Cardlytics is more favorable than Arogo Capital Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cardlytics
1 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.14
Arogo Capital Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Arogo Capital Acquisition has a net margin of 0.00% compared to Cardlytics' net margin of -93.55%. Arogo Capital Acquisition's return on equity of 0.00% beat Cardlytics' return on equity.

Company Net Margins Return on Equity Return on Assets
Cardlytics-93.55% -110.67% -32.70%
Arogo Capital Acquisition N/A N/A N/A

Cardlytics has a beta of 1.53, meaning that its stock price is 53% more volatile than the S&P 500. Comparatively, Arogo Capital Acquisition has a beta of 0.03, meaning that its stock price is 97% less volatile than the S&P 500.

Summary

Cardlytics beats Arogo Capital Acquisition on 10 of the 13 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AOGO vs. The Competition

MetricArogo Capital AcquisitionHolding Offices IndustryUnclassified SectorNASDAQ Exchange
Market Cap$48.76M$422.11M$118.84M$9.08B
Dividend YieldN/A6.38%5.20%4.23%
P/E RatioN/A2.511.5317.18
Price / SalesN/A129.081.33116.95
Price / CashN/A61.1578.6637.86
Price / BookN/A84.22519.874.78
Net IncomeN/A$33.84M$2.37M$225.60M
7 Day Performance1.36%9.49%0.37%-1.23%
1 Month Performance1.45%44.43%46.10%3.36%
1 Year Performance4.57%26.66%23.45%16.60%

Arogo Capital Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AOGO
Arogo Capital Acquisition
N/A$11.21
+0.1%
N/A+4.6%$48.76MN/A0.00N/APositive News
CDLX
Cardlytics
3.1862 of 5 stars
$3.77
+1.1%
$6.92
+83.5%
-56.5%$191.59M$309.20M-0.59457Gap Down
CMCM
Cheetah Mobile
0.8571 of 5 stars
$6.12
-3.3%
N/A+110.8%$182.87M$94.30M0.00850Earnings Report
Analyst Upgrade
News Coverage
CCRD
CoreCard
1.5982 of 5 stars
$21.95
-1.6%
$15.00
-31.7%
+52.4%$173.43M$54.73M45.511,150
CSPI
CSP
0.911 of 5 stars
$17.48
+4.1%
N/A+48.5%$170.68M$57.51M61.29120Earnings Report
News Coverage
Gap Down
MAPS
WM Technology
3.1945 of 5 stars
$1.11
-10.5%
$2.61
+135.1%
+120.9%$169.68M$187.99M-36.65610Gap Up
High Trading Volume
EGAN
eGain
4.0464 of 5 stars
$5.66
+1.6%
$9.50
+67.8%
-28.0%$161.45M$90.43M29.68690Positive News
SKIL
Skillsoft
3.263 of 5 stars
$19.20
+7.3%
$35.00
+82.3%
+24.7%$159.05M$534.78M-0.432,318
SSTI
SoundThinking
2.6687 of 5 stars
$12.15
-2.6%
$21.20
+74.5%
-52.0%$152.97M$92.72M-103.99213High Trading Volume
AILE
iLearningEngines
3.0213 of 5 stars
$1.04
-2.8%
$19.50
+1,775.0%
N/A$146.82MN/A0.00101
ISSC
Innovative Solutions and Support
1.4517 of 5 stars
$7.87
+3.0%
N/A+1.9%$137.73M$44.81M20.6580Earnings Report
Analyst Downgrade
News Coverage
Positive News
Gap Up

Related Companies and Tools


This page (NASDAQ:AOGO) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners